The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%. Immunosuppression reduction is the management cornerstone for BKV and has been shown to be effective at clearing the virus while maintaining graft function in both kidney alone and simultaneous kidney-pancreas transplant recipients. However, there is a lack of published data on the prevalence and outcomes in simultaneous liver-kidney (SLK) transplant recipients.
Study Type
OBSERVATIONAL
Enrollment
50
Simultaneous Liver-Kidney Transplant
Methodist Dallas Medical Center
Dallas, Texas, United States
To characterize the prevalence of BKV in the SLK patient population at MDMC.
number of SLK transplant recipients who were transplanted at MDMC
Time frame: over a 6-year period (2015 to 2020).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.